期刊
CELL
卷 145, 期 5, 页码 758-772出版社
CELL PRESS
DOI: 10.1016/j.cell.2011.03.052
关键词
-
资金
- National Institute of Neurological Disorders and Stroke [5R01NS070301-02]
- National Institute of Mental Health [5P50MH084020-03]
- National 973 Basic Research Program of China [20009CB941400, R21HD065290, R01MH081164]
- Autism Speaks
- Autism Science Foundation
- Hartwell Foundation
- NIDCD
We have created a mouse genetic model that mimics a human mutation of Shank3 that deletes the C terminus and is associated with autism. Expressed as a single copy [Shank3(+/Delta C) mice], Shank3 Delta C protein interacts with the wild-type (WT) gene product and results in >90% reduction of Shank3 at synapses. This gain-of-function phenotype is linked to increased polyubiquitination of WT Shank3 and its redistribution into proteasomes. Similarly, the NR1 subunit of the NMDA receptor is reduced at synapses with increased polyubiquitination. Assays of postsynaptic density proteins, spine morphology, and synapse number are unchanged in Shank3(+/Delta C) mice, but the amplitude of NMDAR responses is reduced together with reduced NMDAR-dependent LTP and LTD. Reciprocally, mGluR-dependent LTD is markedly enhanced. Shank3(+/Delta C) mice show behavioral deficits suggestive of autism and reduced NMDA receptor function. These studies reveal a mechanism distinct from haploinsufficiency by which mutations of Shank3 can evoke an autism-like disorder.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据